外周血和骨髓中γδ T细胞增多，究竟是反应性还是恶性？长期随访的临床结果如何？这两个问题是临床流式诊断经常遇到的难题，Tariq等人在2024年12月25日的Cytometry B杂志上给了我们一些非常重要的线索。

GammaDelta Therapeutics has developed a pipeline of novel allogeneic cell therapies based on its Vδ1+ γδ T cell platforms for the treatment of solid tumors and beyond. Gamma delta (γδ ...

GammaDelta’s drug platform is based on the unique properties of gamma delta (γδ) T cells, a class of lymphocytes that play a role to many types of immune responses and immunopathology.

TC Biopharm (Holdings) plc intends to begin proof-of-concept preclinical studies for its lead therapeutic TCB-008, to treat H5N1, or bird flu. TCB-008 is an allogeneic, unmodified cell therapy ...